Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

DeLauro Whistles For Investigation Of US FDA Response To Whistleblower Report On Abbott Formula Facility

13 May 2022

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US Lawmakers Want Answers From FDA On Infant Formula Shortage Following Abbott Recall

13 May 2022

President’s Request Boosts Food Safety Budget, Proposes Separate Agency

03 Feb 2015

DeLauro Renews Push To Give FDA Mandatory Recall Authority For Drugs

12 Jan 2020

US FDA Critic Leads House Appropriators, Consumer Health Ally Heads Energy And Commerce

03 Dec 2020

Additional Topics

International United States US States FDA Politics Regulation Commercial Companies Compliance Consumer Dietary Supplements Enforcement Ingredients Manufacturing Policy Recalls Safety

More from International

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.